19 Recruiting Studies Using Axitinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Axitinib
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
📍 Columbia University Irving Medical Center — New York, New York
Pheochromocytoma
View Study & Checklist ➔A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Renal Cell Carcinoma
View Study & Checklist ➔Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
📍 Johns Hopkins — Baltimore, Maryland
Renal Cell Carcinoma
View Study & Checklist ➔Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab
📍 University of Iowa Hospitals & Clinics — Iowa City, Iowa
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Metastatic Renal Cell Carcinoma
View Study & Checklist ➔Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
📍 University of Chicago — Chicago, Illinois
Metastatic Endometrial Cancer
View Study & Checklist ➔Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
Advanced Malignancies
View Study & Checklist ➔Prior Axitinib as a Determinant of Outcome of Renal Surgery
📍 UC San Diego Moores Cancer Center — La Jolla, California
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Axitinib + Ipilimumab in Advanced Melanoma
📍 Moffitt Cancer Center — Tampa, Florida
Melanoma
View Study & Checklist ➔A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
📍 Research Site — Washington D.C., District of Columbia
Advanced Renal Cell Carcinoma
View Study & Checklist ➔Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
📍 Los Angeles County-USC Medical Center — Los Angeles, California
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
📍 Cross Cancer Institute — Edmonton, Alberta
Lymphoma, Non-Hodgkin
View Study & Checklist ➔Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
📍 Mayo Clinic Building- Phoenix — Phoenix, Arizona
Carcinoma, Renal Cell
View Study & Checklist ➔A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
📍 Brigham and Women's Hospital — Boston, Massachusetts
Metastatic Renal Cell Carcinoma
View Study & Checklist ➔Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
📍 University of Colorado Cancer Center — Aurora, Colorado
Renal Cancer
View Study & Checklist ➔Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
📍 Memorial Sloan Kettering Westchester — Harrison, New York
Mucosal Melanoma
View Study & Checklist ➔Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
📍 Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas
Advanced Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Renal Cell Carcinoma
View Study & Checklist ➔